We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $550B Turnover 5.35%
1-Year Est. Return 43.33%
 

UBS AM is the US asset manager of UBS and grew out of Brinson Partners, an investment firm founded by Gary Brinson and made independent in 1989. Swiss Bank Corporation bought Brinson Partners in 1994, and once the bank merged with UBS, its founder Gary Brinson, who had run Swiss Bank's asset management business, became chief investment officer of UBS Asset Management. In 2024 the business took in Credit Suisse Asset Management and two of its own units, UBS Hedge Fund Solutions and UBS O’Connor, though the O’Connor business was later sold. Its clients are mainly institutions such as retirement plans, government bodies, endowments and foundations.

This Fund
S&P 500
This Quarter Est. Return
+29.03%
1 Year Est. Return
+43.33%
3 Year Est. Return
+132.06%
5 Year Est. Return
+165.07%
10 Year Est. Return
+656.77%
AUM
$550B
AUM Growth
+$69.1B
Cap. Flow
-$11.9B
Cap. Flow %
-2.17%
Top 10 Hldgs %
32.74%
Holding
3,886
New
45
Increased
996
Reduced
1,636
Closed
163
Avg Time Held
5.1 years
Top 10 Avg Time Held
2.7 years
Top 20 Avg Time Held
4.5 years

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$1.73B
2
ETN icon
Eaton
ETN
+$1.21B
3
STX icon
Seagate
STX
+$1.1B
4
TT icon
Trane Technologies
TT
+$1.02B
5
ACN icon
Accenture
ACN
+$1.01B

Sector Composition

Rank Sector Weight
1 Technology 40.05%
2 Financials 11.12%
3 Healthcare 9.54%
4 Consumer Discretionary 9.09%
5 Communication Services 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
EFA icon
1276
iShares MSCI EAFE ETF
EFA
$76.7B
$8.98M ﹤0.01%
86,458
-25,514
-23% -$2.62M
2025 Q4
2 quarters
ROAD icon
1277
Construction Partners
ROAD
$5.1B
$8.97M ﹤0.01%
75,557
-528
-0.7% -$62.7K
2020 Q3
23 quarters
VKTX icon
1278
Viking Therapeutics
VKTX
$3.48B
$8.97M ﹤0.01%
229,973
-23,921
-9% -$773K
2023 Q3
11 quarters
WLY icon
1279
John Wiley & Sons Class A
WLY
$2.59B
$8.93M ﹤0.01%
184,159
+16,217
+10% +$682K
2013 Q2
52 quarters
CPRX icon
1280
DELISTED
Catalyst Pharmaceutical
CPRX
$8.93M ﹤0.01%
284,154
+3,265
+1% +$96.4K
2019 Q2
28 quarters
BAM icon
1281
Brookfield Asset Management
BAM
$77.1B
$8.91M ﹤0.01%
198,723
– –
2025 Q4
2 quarters
AWR icon
1282
American States Water
AWR
$3.42B
$8.87M ﹤0.01%
107,311
-5,513
-5% -$427K
2023 Q1
13 quarters
IDV icon
1283
iShares International Select Dividend ETF
IDV
$8.34B
$8.86M ﹤0.01%
213,805
-1,033
-0.5% -$45.2K
2025 Q4
2 quarters
BOOT icon
1284
Boot Barn
BOOT
$3.95B
$8.85M ﹤0.01%
53,879
-9,732
-15% -$1.58M
2023 Q1
13 quarters
ABG icon
1285
Asbury Automotive
ABG
$3.56B
$8.85M ﹤0.01%
44,005
-398
-0.9% -$78.4K
2023 Q1
13 quarters
NMIH icon
1286
NMI Holdings
NMIH
$3.21B
$8.84M ﹤0.01%
215,188
+19,128
+10% +$731K
2015 Q4
42 quarters
KN icon
1287
Knowles
KN
$2.78B
$8.82M ﹤0.01%
212,691
+14,222
+7% +$494K
2014 Q1
49 quarters
APGE icon
1288
DELISTED
Apogee Therapeutics
APGE
$8.82M ﹤0.01%
66,433
+10,081
+18% +$908K
2024 Q2
8 quarters
CIB icon
1289
Grupo Cibest SA
CIB
$21.7B
$8.78M ﹤0.01%
110,543
+110,458
+129,951% +$7.98M
2025 Q3
3 quarters
ACGL icon
1290
Arch Capital
ACGL
$34.7B
$8.76M ﹤0.01%
90,225
-3,089,527
-97% -$291M
2013 Q2
52 quarters
FFIN icon
1291
First Financial Bankshares
FFIN
$4.39B
$8.74M ﹤0.01%
252,656
+10,244
+4% +$331K
2013 Q2
52 quarters
CGHM icon
1292
Capital Group Municipal High-Income ETF
CGHM
$3.64B
$8.73M ﹤0.01%
337,790
– –
2026 Q1
1 quarter
BILL icon
1293
BILL Holdings
BILL
$4.12B
$8.73M ﹤0.01%
241,431
-95,398
-28% -$3.51M
2020 Q2
24 quarters
TCBI icon
1294
Texas Capital Bancshares
TCBI
$4.42B
$8.7M ﹤0.01%
84,272
-2,493
-3% -$250K
2013 Q2
52 quarters
UFPI icon
1295
UFP Industries
UFPI
$4.52B
$8.66M ﹤0.01%
95,451
-10,728
-10% -$934K
2013 Q3
51 quarters
ARCB icon
1296
ArcBest
ARCB
$2.8B
$8.63M ﹤0.01%
60,108
+5,371
+10% +$699K
2017 Q3
35 quarters
SN icon
1297
SharkNinja
SN
$29.3B
$8.63M ﹤0.01%
56,655
-66,459
-54% -$7.96M
2024 Q2
8 quarters
LRN icon
1298
Stride
LRN
$3.29B
$8.62M ﹤0.01%
99,919
-7,575
-7% -$696K
2017 Q1
37 quarters
AAP icon
1299
Advance Auto Parts
AAP
$2.72B
$8.62M ﹤0.01%
138,474
-21,940
-14% -$1.25M
2013 Q2
52 quarters
MIR icon
1300
Mirion Technologies
MIR
$4.51B
$8.62M ﹤0.01%
480,488
-26,698
-5% -$495K
2022 Q2
16 quarters

Similar funds

UBS AM's Q2 2026 Portfolio in Review

As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.

  • UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
  • UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
  • UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
  • UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
  • UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
  • UBS AM opened 45 new positions and closed 163 in Q2 2026.
  • UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.